M7H-83177-19812
2 vaccinations
1 coded response
1 check-in
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 135 / NY
- Registered
- 2022-01-11
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-02
Dose 1 — Moderna
-
2022-01-07
Dose 2 — Pfizer-BioNTech
-
2022-01-11
Registered in v-safe
-
2022-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Fair · Site: Pain · None · Get care from a doctor or other healthcare professionalFree text: Referral to nose ear ans tbroat dr.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-11
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2022-01-12
- 2022-01-13
-
2022-01-13
Callback requested for04:00PM ET
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-02 | Moderna | No |
| 2 | 2022-01-07 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 2
Healthcare visit (other): Referral to nose ear ans tbroat dr.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release